These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24150229)

  • 1. Postoperative infliximab and elemental diet combination in a case with diffuse, extensive jejunoileal Crohn's disease.
    Matsuda S; Bamba T; Sohma S; Yamamoto T
    Int J Colorectal Dis; 2014 Feb; 29(2):265-6. PubMed ID: 24150229
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of an elemental diet in Crohn's disease.
    Takahashi H; Ando T; Watanabe O; Maeda O; Ishiguro K; Ohmiya N; Niwa Y; Goto H
    Inflammopharmacology; 2007 Feb; 15(1):15-7. PubMed ID: 17323189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concurrent elemental diet on infliximab treatment for Crohn's disease.
    Tanaka T; Takahama K; Kimura T; Mizuno T; Nagasaka M; Iwata K; Nakano H; Muramatsu M; Takazoe M
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1143-9. PubMed ID: 16824066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab prevents Crohn's disease recurrence after ileal resection.
    Regueiro M; Schraut W; Baidoo L; Kip KE; Sepulveda AR; Pesci M; Harrison J; Plevy SE
    Gastroenterology; 2009 Feb; 136(2):441-50.e1; quiz 716. PubMed ID: 19109962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record?
    Sorrentino D
    Inflamm Bowel Dis; 2012 Sep; 18(9):1624-5; author reply 1626-7. PubMed ID: 22359378
    [No Abstract]   [Full Text] [Related]  

  • 6. Issues surrounding postoperative therapy in Crohn's disease to prevent recurrence.
    Morar P; Hart A; Warusavitarne J
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1763-4. PubMed ID: 24561509
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-tumor necrosis factor therapy to prevent Crohn's disease recurrence after surgery.
    Herfarth HH
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1503-6. PubMed ID: 24534549
    [No Abstract]   [Full Text] [Related]  

  • 8. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).
    Eshuis EJ; Bemelman WA; van Bodegraven AA; Sprangers MA; Bossuyt PM; van Milligen de Wit AW; Crolla RM; Cahen DL; Oostenbrug LE; Sosef MN; Voorburg AM; Davids PH; van der Woude CJ; Lange J; Mallant RC; Boom MJ; Lieverse RJ; van der Zaag ES; Houben MH; Vecht J; Pierik RE; van Ditzhuijsen TJ; Prins HA; Marsman WA; Stockmann HB; Brink MA; Consten EC; van der Werf SD; Marinelli AW; Jansen JM; Gerhards MF; Bolwerk CJ; Stassen LP; Spanier BW; Bilgen EJ; van Berkel AM; Cense HA; van Heukelem HA; van de Laar A; Slot WB; Eijsbouts QA; van Ooteghem NA; van Wagensveld B; van den Brande JM; van Geloven AA; Bruin KF; Maring JK; Oldenburg B; van Hillegersberg R; de Jong DJ; Bleichrodt R; van der Peet DL; Dekkers PE; Goei TH; Stokkers PC
    BMC Surg; 2008 Aug; 8():15. PubMed ID: 18721465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infliximab treatment of severe bleeding complicating Crohn's disease].
    Julián Gómez L; Atienza R; Barrio J; Gil P; Gómez de la Cuesta S; Pinto P; Alcaide N; Caro Patón A
    Rev Esp Enferm Dig; 2010 Jan; 102(1):57-8. PubMed ID: 20187687
    [No Abstract]   [Full Text] [Related]  

  • 11. Postoperative Crohn's disease: how can we prevent it?
    Swoger JM; Regueiro M
    Expert Rev Clin Immunol; 2010 Jul; 6(4):501-4. PubMed ID: 20594119
    [No Abstract]   [Full Text] [Related]  

  • 12. A rare case of free bowel perforation associated with infliximab treatment for stricturing Crohn's disease.
    Lim CS; Moon W; Park SJ; Park MI; Kim HH; Kim JB; Choi JM; Chang HK; Lee SH
    Korean J Gastroenterol; 2013 Sep; 62(3):169-73. PubMed ID: 24077628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients.
    Appau KA; Fazio VW; Shen B; Church JM; Lashner B; Remzi F; Brzezinski A; Strong SA; Hammel J; Kiran RP
    J Gastrointest Surg; 2008 Oct; 12(10):1738-44. PubMed ID: 18709420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease.
    Regueiro M; El-Hachem S; Kip KE; Schraut W; Baidoo L; Watson A; Swoger J; Schwartz M; Barrie A; Pesci M; Binion D
    Dig Dis Sci; 2011 Dec; 56(12):3610-5. PubMed ID: 21681507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis.
    Yang ZP; Hong L; Wu Q; Wu KC; Fan DM
    Int J Surg; 2014; 12(3):224-30. PubMed ID: 24394691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
    Ponsioen CY; de Groof EJ; Eshuis EJ; Gardenbroek TJ; Bossuyt PMM; Hart A; Warusavitarne J; Buskens CJ; van Bodegraven AA; Brink MA; Consten ECJ; van Wagensveld BA; Rijk MCM; Crolla RMPH; Noomen CG; Houdijk APJ; Mallant RC; Boom M; Marsman WA; Stockmann HB; Mol B; de Groof AJ; Stokkers PC; D'Haens GR; Bemelman WA;
    Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):785-792. PubMed ID: 28838644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.
    Beppu T; Ono Y; Matsui T; Hirai F; Yano Y; Takatsu N; Ninomiya K; Tsurumi K; Sato Y; Takahashi H; Ookado Y; Koga A; Kinjo K; Nagahama T; Hisabe T; Takaki Y; Yao K
    Dig Endosc; 2015 Jan; 27(1):73-81. PubMed ID: 24833527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
    Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in Japan.
    Fukushima K; Sugita A; Futami K; Takahashi KI; Motoya S; Kimura H; Yoshikawa S; Kinouchi Y; Iijima H; Endo K; Hibi T; Watanabe M; Sasaki I; Suzuki Y;
    Surg Today; 2018 Jun; 48(6):584-590. PubMed ID: 29383596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab in the surgical management of complex fistulating anal Crohn's disease.
    Talbot C; Sagar PM; Johnston MJ; Finan PJ; Burke D
    Colorectal Dis; 2005 Mar; 7(2):164-8. PubMed ID: 15720356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.